• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】16602

【品名】ethyl formate

【CA登记号】109-94-4

【 分 子 式 】C3H6O2

【 分 子 量 】74.07944

【元素组成】C 48.64% H 8.16% O 43.2%

与该中间体有关的原料药合成路线共 17 条

合成路线1

该中间体在本合成路线中的序号:(XXI)

Treatment of cyclopropane-1,1-dicarboxylic acid (IX) with one equivalent of SOCl2 in the presence of Et3N in THF at 0 °C, followed by condensation of the activated intermediate with 4-fluoroaniline (X), provides the monoamide (XI) , which is optionally chlorinated to (VIII) by treatment with oxalyl chloride in cold THF .
Reaction of 3,4-difluoronitrobenzene (XII) with sodium benzylate prepared from benzyl alcohol and NaH in dimethylacetamide gives 1-benzyloxy-2-fluoro-4-nitrobenzene (XIII) as the main product. Subsequent reduction of compound (XIII) by means of iron and ammonium formate in refluxing toluene leads to the corresponding aniline (XIV), which is subsequently coupled with carboxylic acid (XI) using EDC in CH2Cl2 to afford the diamide (XV). Finally, debenzylation of diamide (XV) by transfer hydrogenation with 1,4-cyclohexadiene and Pd/C in boiling EtOH provides the target intermediate (I) . Scheme 2. Alternatively, acid chloride (VIII) can be directly condensed with 4-amino-2-fluorophenol (XVI) in the presence of 2,6-lutidine in cold THF to give diamide (I) .

1 Bannen, L.C., Chan, D.S.-M., Chen, J. (Exelixis, Inc.). c-Met modulators and methods of use. EP 1673085, EP 2210607, EP 2213661, JP 2007506777, JP 2010235631, JP 2010235632, WO 2005030140.
2 Forsyth, T.P., Mac, M.B., Leahy, J.W., Nuss, J.M., Xu, W.(Exelixis, Inc.). c-Met modulators and methods of use. EP 1874759, JP 2008537748, US 2008161305, WO 2006108059.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 69103 7-(benzyloxy)-6-methoxyquinolin-4-yl trifluoromethanesulfonate   C18H14F3NO5S 详情 详情
(XVII) 22604 1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone 498-02-2 C9H10O3 详情 详情
(XVIII) 69112 1-(4-(benzyloxy)-3-methoxyphenyl)ethanone;3'-Methoxy-4'-(benzyloxy)acetophenone;4'-(Benzyloxy)-3'-methoxyacetophenone;Acetovanillone benzyl ether;1-(3-Methoxy-4-phenylmethoxyphenyl)ethanone 1835-11-6 C16H16O3 详情 详情
(XIX) 69113 1-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)ethanone;4’-benzyloxy-5’-methoxy-2’-nitroacetophenone   C16H15NO5 详情 详情
(XX) 69114 1-(2-amino-4-(benzyloxy)-5-methoxyphenyl)ethanone   C16H17NO3 详情 详情
(XXI) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(XXII) 67631 7-(benzyloxy)-6-methoxyquinolin-4-ol   C17H15NO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

The condensation of 6-methylpyridine-3-carboxaldehyde (I) with malonic acid (II) by means of piperidine in refluxing pyridine gives 3-(6-methyl-3-pyridyl)acrylic acid (III), which is esterified with ethanol and H2SO4 as usual to afford ethyl 3-(6-methyl-3-pyridyl)acrylate (IV). The reduction of (IV) with H2 over Pd/C in ethanol affords ethyl 3-(6-methyl-3-pyridyl)propionate (V), which is cyclized with ethyl formate (VI) and thiourea (VII) by means of Na in ether-ethanol yielding 5-(6-methyl-3-pyridylmethyl)-2-thiouracil (VIII). The methylation of (VIII) with methyl iodide and NaOH in hot water gives 5-(6-methyl-3-pyridyl-methyl)-2-methylthio-4-pyrimidone (IX), which is finally condensed with 2-[(5-dimethylaminomethylfuran-2-yl)methylthio]ethylamine (X) in refluxing pyridine.

1 Brown, T.H.; Ife, R.J. (SmithKline Beecham plc); Pyrimidine compounds. DD 140252; EP 0003677; ES 477667; US 4234588; US 4649141 .
2 de Angelis, L.; Serradell, M.N.; Castaner, J.; Blancafort, P.; SKF-93,479. Drugs Fut 1982, 7, 3, 175.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22949 6-methylnicotinaldehyde C7H7NO 详情 详情
(II) 12963 Malonic acid 141-82-2 C3H4O4 详情 详情
(III) 22950 (E)-3-(6-methyl-3-pyridinyl)-2-propenoic acid C9H9NO2 详情 详情
(IV) 36446 ethyl (E)-3-(6-methyl-3-pyridinyl)-2-propenoate C11H13NO2 详情 详情
(V) 22951 ethyl 3-(6-methyl-3-pyridinyl)propanoate C11H15NO2 详情 详情
(VI) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(VII) 10180 Thiourea 62-56-6 CH4N2S 详情 详情
(VIII) 36447 5-[(6-methyl-3-pyridinyl)methyl]-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone C11H11N3OS 详情 详情
(IX) 36448 5-[(6-methyl-3-pyridinyl)methyl]-2-(methylsulfanyl)-4(3H)-pyrimidinone C12H13N3OS 详情 详情
(X) 13851 2-[([5-[(Dimethylamino)methyl]-2-furyl]methyl)sulfanyl]-1-ethanamine; N-[(5-[[(2-Aminoethyl)sulfanyl]methyl]-2-furyl)methyl]-N,N-dimethylamine C10H18N2OS 详情 详情

合成路线3

该中间体在本合成路线中的序号:(A)

The reaction of dl-l-phenylethylamine (I) with ethyl chloroacetate (II) by means of triethylamine in DMF gives dl-N-[(ethoxycarbonyl)methyl]-1-phenylethylamine (III), which is then treated with formic acid in refluxing xylene yielding dl-N-formyl-N-[(ethoxycarbonyl)methyl]-1-phenylethylamine (IV). The reaction of (IV) with sodium ethoxide and ethyl formate (A) in THF affords dl-N-formyl-N-[(ethoxycarbonyl)-2-hydroxyvinyl]-1-phenylethylamine (V), which, without purification, is treated with potassium thiocyanate and HCl in diisopropyl ether to give dl-l-(phenylethyl)-2-mercapto-5-ethoxycarbonylimidazole (VI). This product is finally treated with nitric acid and sodium nitrate at room temperature. The optical active drugs can be obtained starting the synthesis with the optically active amine (I).

1 Godefroi, E.F.; et al.; Imidazole carboxylates. BE 0662474; DE 1545988; FR 4499M; GB 1064531; US 3354173 .
2 Roberts, P.J.; Castaner, J.; Etomidate. Drugs Fut 1976, 1, 10, 461.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(I) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(II) 16601 ethyl chloroacetate; ethyl 2-chloroacetate 105-39-5 C4H7ClO2 详情 详情
(III) 34103 ethyl 2-[[(1R)-1-phenylethyl]amino]acetate C12H17NO2 详情 详情
(IV) 34104 ethyl 2-[formyl[(1R)-1-phenylethyl]amino]acetate C13H17NO3 详情 详情
(V) 34105 ethyl (Z)-2-[formyl[(1R)-1-phenylethyl]amino]-3-hydroxy-2-propenoate C14H17NO4 详情 详情
(VI) 34106 ethyl 1-[(1R)-1-phenylethyl]-2-sulfanyl-1H-imidazole-5-carboxylate C14H16N2O2S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(B)

4) By reaction of the nitrile (I) with ethyl formate (B) by means of NaOEt in ethanol to give alpha-formyl-2,6-dichlorophenylacetonitrile (III), which is condensed with guanidine hydrochloride (A) by means of NaOEt in ethanol to yield alpha-(guanidinomethylene)-2,6-dichlorophenylacetonitrile (IV); this product is finally hydrolyzed and rearranged by means of HCl.

1 Arrigoni-Martelli, E.; Castaner, J.; BS 100-141. Drugs Fut 1976, 1, 4, 167.
2 Bream, J.B.; et al.; Verfahren zur Herstellung von Acylguanidinen. CH 511816 .
3 Bream, J.B.; et al.; Verfahren zur Herstellung von Acylguanidinen. CH 518910 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 14790 Guanidine 113-00-8 CH5N3 详情 详情
(B) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(I) 18202 2-(2,6-dichlorophenyl)acetonitrile; 2,6-Dichlorophenylacetonitrile 3215-64-3 C8H5Cl2N 详情 详情
(III) 40331 2-(2,6-dichlorophenyl)-2-hydroxyacetonitrile C8H5Cl2NO 详情 详情
(IV) 40332 N''-[(Z)-2-cyano-2-(2,6-dichlorophenyl)ethenyl]guanidine C10H8Cl2N4 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

The cyclization of the imidazolyl riboside (I) with [13C]-formic acid ethyl ester (II) by means of sodium ethoxide in refluxing ethanol gives labeled inosine (III), which is acetylated with Ac2O and pyridine yielding the triacetate (IV). The nitration of (IV) with ammonium nitrate and trifluoroacetic anhydride affords the 1-nitroinosine (V), which is rearranged with 15NH4Cl in acetonitrile/water to provide the doubly labeled inosine (VI). The reaction of (VI) with SOCl2 gives the chloropurine (VII), which is condensed with the dideuterated 2-aminocyclopentanol (rac-trans)-(VIII) (obtained by hydrogenation of the unsaturated analogue (rac-trans)-(IX)) by means of NaHCO3 in isopropanol providing a diastereomeric mixture (X). The deacetylation of (X) with tert-butylamine in methanol furnishes a mixture of the target compound along with its diastereomer, which is separated by preparative HPLC.

1 Wadsworth, A.H.; et al.; Synthesis of isotopically labelled versions of adenosine agonist GR79236. J Label Compd Radiopharm 2000, 43, 1, 11.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV),(VI) 38014 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H18N4O8 详情 详情
(I) 37427 5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-1H-imidazole-4-carboxamide C9H14N4O5 详情 详情
(II) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(II) 45175 ethyl formate C3H6O2 详情 详情
(III) 38013 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-1,9-dihydro-6H-purin-6-one C10H12N4O5 详情 详情
(III) 45176 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-1,9-dihydro-6H-purin-6-one C10H12N4O5 详情 详情
(IV) 45177 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H18N4O8 详情 详情
(V) 38015 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(1-nitro-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H17N5O10 详情 详情
(V) 45178 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(1-nitro-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H17N5O10 详情 详情
(VI) 45179 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H18N4O8 详情 详情
(VII) 38016 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-chloro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H17ClN4O7 详情 详情
(VII) 45180 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-chloro-9H-purin-9-yl)tetrahydro-3-furanyl acetate C16H17ClN4O7 详情 详情
(VIII) 38010 (1S,2S)-2-aminocyclopentanol C5H11NO 详情 详情
(VIII) 45181 (1S,2S)-2-aminocyclopentanol C5H11NO 详情 详情
(IX) 38017 (1S,2S)-2-amino-3-cyclopenten-1-ol C5H9NO 详情 详情
(X) 38018 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-[[(1S,2S)-2-hydroxycyclopentyl]amino]-9H-purin-9-yl)tetrahydro-3-furanyl acetate C21H27N5O8 详情 详情
(X) 45182 (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-(6-[[(1S,2S)-2-hydroxycyclopentyl]amino]-9H-purin-9-yl)tetrahydro-3-furanyl acetate C21H27N5O8 详情 详情

合成路线6

该中间体在本合成路线中的序号:(B)

The condensation of cyclohexene-epoxide (I) with pyrrolidine (II) gives trans-2-(1-pyrrolidinyl)cyclohexanol (III), which by reaction with NaH and methanesulfonyl chloride, and then with benzylamine is converted into trans-2-(1-pyrrolidinyl)-N-benzylcyclohexylamine (IV). The debenzylation of (IV) by hydrogenolysis with H2 over Pd/C affords trans-2-(1-pyrrolidinyl)cyclohexylamine (V), which is formylated with ethyl formate to the corresponding N-formyl-trans-2-(1-pyrrolidinyl)cyclohexylamine (VI). The reduction of (VI) with LiAlH4 in refluxing ether gives trans-N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (VII), which is finally condensed with 3,4-dichlorophenylacetic acid (VIII) by means of carbonyl diimidazole (IX) in THF.

1 Blancafort, P.; Castaner, J.; Serradell, M.N.; U-50488. Drugs Fut 1982, 7, 6, 416.
2 Szmuszkovicz, J.; 2-Aminocycloaliphatic amide compounds. DE 2749950; ES 463876; FR 2370723; GB 1569225; JP 53063351; JP 61233654; US 4145435 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 15147 Benzylamine; Phenylmethanamine 100-46-9 C7H9N 详情 详情
(B) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(I) 17986 7-oxabicyclo[4.1.0]heptane; cyclohexene oxide 286-20-4 C6H10O 详情 详情
(II) 11376 Pyrrolidine 123-75-1 C4H9N 详情 详情
(III) 14637 (1R,2R)-2-(1-pyrrolidinyl)cyclohexanol C10H19NO 详情 详情
(IV) 37038 N-phenyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]amine; N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]aniline C16H24N2 详情 详情
(V) 37040 (1R,2R)-2-(1-pyrrolidinyl)cyclohexylamine; (1R,2R)-2-(1-pyrrolidinyl)cyclohexanamine C10H20N2 详情 详情
(VI) 37011 1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)-2-propen-1-one C15H20N2O 详情 详情
(VII) 31357 N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]amine; (1R,2R)-N-methyl-2-(1-pyrrolidinyl)cyclohexanamine C11H22N2 详情 详情
(VIII) 30414 2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid 5807-30-7 C8H6Cl2O2 详情 详情
(IX) 11353 1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole) 530-62-1 C7H6N4O 详情 详情
(X) 37039 7-azabicyclo[4.1.0]heptane C6H11N 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XVIII)

The thiazolyl carbonate (XI) has been synthesized as follows: The reaction of formamide (XIV) with P2S5 in ethyl ether gives thioformamide (XV), which is cyclized with 2-chloro-3-oxopropionic acid ethyl ester (XVI) [obtained by condensation of ethyl chloroacetate (XVII) with ethyl formate (XVIII) by means of t-BuOK in THF] yielding thiazol-5-carboxylic acid ethyl ester (XIX). The reduction of (XIX) with LiAlH4 in THF affords 5-thiazolylmethanol (XX), which is then esterified with 4-nitrophenyl chloroformate (XXI) by means of 4-methylmorpholine (MPH) in dichloromethane to give the desired product (XI).

1 Graul, A.; Castañer, J.; Ritonavir. Drugs Fut 1996, 21, 7, 700.
2 Kempf, D.J.; Norbeck, D.W.; Sham, H.L.; Zhao, C.; Sowin, T.J.; Reno, D.S.; Haight, A.R.; Cooper, A.J. (Abbott Laboratories Inc.); Retroviral protease inhibiting cpds. EP 0674513; EP 0727419; JP 1996505844; JP 1997118679; JP 1998087639; WO 9414436 .
3 Al-Razzak, L.; Marsh, K.C.; Manning, L.P.; Kaul, D. (Abbott Laboratories Inc.); Pharmaceutical compsns. containing HIV protease inhibitors. EP 0732923; US 5484801; WO 9520384 .
4 Flentge, C.; Kempf, D.; Marsh, K.; et al.; Symmetry-based inhibitors of HIV protease with high oral bioavailability. 207th ACS Natl Meet (March 13-17, San Diego) 1994, Abst MEDI 35.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 16595 4-nitrophenyl 1,3-thiazol-5-ylmethyl carbonate 144163-97-3 C11H8N2O5S 详情 详情
(XIV) 16598 Formamide 75-12-7 CH3NO 详情 详情
(XV) 16599 Thioformamide CH3NS 详情 详情
(XVI) 16600 ethyl 2-chloro-3-oxopropanoate C5H7ClO3 详情 详情
(XVII) 16601 ethyl chloroacetate; ethyl 2-chloroacetate 105-39-5 C4H7ClO2 详情 详情
(XVIII) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(XIX) 16603 ethyl 1,3-thiazole-5-carboxylate 32955-22-9 C6H7NO2S 详情 详情
(XX) 16604 1,3-thiazol-5-ylmethanol;5-thiazolylmethanol;Thiazole-5-methanol 38585-74-9 C4H5NOS 详情 详情
(XXI) 16605 4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene 7693-46-1 C7H4ClNO4 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The reaction of ethyl chloroacetate (I) with ethyl formate (II) by means of potassium tert-butoxide in diisopropyl ether gives the 2-formylchloroacetate (III), which is cyclized with 6-methylpyridine-2-amine (IV) by means of conc. H2SO4, yielding 5-methylimidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester (V). The chlorination of (V) with NCS in THF affords the chloromethyl derivative (VI), which is condensed with the monoprotected diamine (VII) by means of TEA to provide the adduct (VIII). The cyclization of (VIII) by means of NaOMe, TEA and NaI in DMF gives 4-[4-(benzyloxycarbonylamino)butyl]-4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one (IX), which is deprotected with H2 over Pd/C in MeOH, yielding the butylamine derivative (X). Finally, this compound is sulfonated with N-phenyltrifluoromethylsulfonimide (XI) and TEA in DMF.

1 Ikemoto, T.; et al.; A practical synthesis of the chronic renal disease agent, 4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one derivatives, using regioselective chlorination of ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxy with N-chlorosuccinimide. Tetrahedron 2000, 56, 40, 7915.
2 Takatani, M.; Shibouta, Y.; Tomimatsu, K.; Kawamoto, T. (Takeda Chemical Industries, Ltd.); Tricyclic cpds., their production and use. EP 0771319; JP 1996081467; WO 9602542 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10257 methyl 2-chloroacetate; methyl chloroacetate 96-34-4 C3H5ClO2 详情 详情
(II) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(III) 16600 ethyl 2-chloro-3-oxopropanoate C5H7ClO3 详情 详情
(IV) 19678 6-methyl-2-pyridinamine; 6-methyl-2-pyridinylamine; 6-amino-2-picoline; 2-Amino-6-methylpyridine 1824-81-3 C6H8N2 详情 详情
(V) 42075 ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate C11H12N2O2 详情 详情
(VI) 42076 ethyl 5-(chloromethyl)imidazo[1,2-a]pyridine-3-carboxylate C11H11ClN2O2 详情 详情
(VII) 42077 benzyl 4-aminobutylcarbamate 62146-62-7 C12H18N2O2 详情 详情
(VIII) 42078 ethyl 5-[[(4-[[(benzyloxy)carbonyl]amino]butyl)amino]methyl]imidazo[1,2-a]pyridine-3-carboxylate C23H28N4O4 详情 详情
(IX) 42079 benzyl 4-(3-oxo-3,5-dihydro-4H-1,4,8b-triazaacenaphthylen-4-yl)butylcarbamate C21H22N4O3 详情 详情
(X) 42080 4-(4-aminobutyl)-4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one C13H16N4O 详情 详情
(XI) 17573 N-Phenyltrifluoromethanesulfonimide; Trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide 37595-74-7 C8H5F6NO4S2 详情 详情

合成路线9

该中间体在本合成路线中的序号:

Claisen condensation of 3-beta-acetyloxypregna-5,16-dien-20-one (I) with ethyl formate in the presence of NaOMe in pyridine, with simultaneous deacetylation, provided the corresponding 21-formyl derivative (II). Subsequent treatment of (II) with hydroxylamine yielded isoxazole (III) as the only regioisomer. Finally, Oppenauer oxidation of (III) with cyclohexanone and aluminum isopropoxide gave rise to the target alpha,beta-unsaturated ketone.

1 Ling, Y.; et al.; 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives, novel steroidal inhibitors of human cytochrome C17,20-lyase (P45017alpha). J Med Chem 1997, 40, 20, 3297.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(I) 32586 (3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate 979-02-2 C23H32O3 详情 详情
(II) 32587 (Z)-3-hydroxy-1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-propen-1-one C22H30O3 详情 详情
(III) 32588 (3S,8R,9S,10R,13S,14S)-17-(5-isoxazolyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C22H29NO2 详情 详情

合成路线10

该中间体在本合成路线中的序号:

Keto oxime (IV) was converted to the syn amino alcohol (XII) by palladium-catalyzed hydrogenation. Subsequent N-methylation of (XII) to give (XIV) was then achieved via formylation of the primary amine to formamide (XIII) in refluxing ethyl formate, followed by borane reduction. Acylation of the secondary amine (XIV) with N-(benzyloxycarbonyl)piperidine-4-carbonyl chloride (XV) provided amide (XVI). After Swern oxidation of the alcohol group of (XVI), the keto amide (XVII) was cyclized to the desired imidazole (VIII) in boiling ammonium formate.

1 Claiborne, C.F.; et al.; An efficient synthesis of tetrasubstituted imidazoles from N-(2-oxo)-amides. Tetrahedron Lett 1998, 39, 49, 8939.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(IV) 35155 1-(2-fluoro-4-pyridinyl)-2-[3-(trifluoromethyl)phenyl]-1,2-ethanedione 1-oxime C14H8F4N2O2 详情 详情
(VIII) 35159 benzyl 4-[5-(2-fluoro-4-pyridinyl)-1-methyl-4-[3-(trifluoromethyl)phenyl]-1H-imidazol-2-yl]-1-piperidinecarboxylate C29H26F4N4O2 详情 详情
(XII) 35162 (1S,2R)-2-amino-2-(2-fluoro-4-pyridinyl)-1-[3-(trifluoromethyl)phenyl]-1-ethanol C14H12F4N2O 详情 详情
(XIII) 35163 (1R,2S)-1-(2-fluoro-4-pyridinyl)-2-hydroxy-2-[3-(trifluoromethyl)phenyl]ethylformamide C15H12F4N2O2 详情 详情
(XIV) 35164 (1S,2R)-2-(2-fluoro-4-pyridinyl)-2-(methylamino)-1-[3-(trifluoromethyl)phenyl]-1-ethanol C15H14F4N2O 详情 详情
(XV) 35165 benzyl 4-(chlorocarbonyl)-1-piperidinecarboxylate C14H16ClNO3 详情 详情
(XVI) 35166 benzyl 4-[[[(1R,2S)-1-(2-fluoro-4-pyridinyl)-2-hydroxy-2-[3-(trifluoromethyl)phenyl]ethyl](methyl)amino]carbonyl]-1-piperidinecarboxylate C29H29F4N3O4 详情 详情
(XVII) 35167 benzyl 4-[[[(1R)-1-(2-fluoro-4-pyridinyl)-2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl](methyl)amino]carbonyl]-1-piperidinecarboxylate C29H27F4N3O4 详情 详情

合成路线11

该中间体在本合成路线中的序号:(XII)

Alternatively, the desired compound can be obtained as follows: Treatment of diethyl cyanomethyl phosphonate (VII) with NaH in dimethoxyethane (DME) followed by reaction with 3,3'-difluorobenzophenone (VIII) gives alkene derivative (IX), which is then hydrogenated over Pd(OH)2 to provide compound (X). Reduction of the cyano moiety of (X) by means of B2H6-THF followed by treatment with refluxing HCl yields substituted propylamine (XI), which is then converted into formamide (XIII) by treatment with refluxing ethyl formate (XII). Compound (XIII) is then reduced by means of borane-methyl sulfide in refluxing THF and finally treated with HCl. Propylamine (XI) can also be obtained following these steps: Treatment of benzophenone derivative (VIII) with n-BuLi and acetonitrile in THF affords cyano derivative (XIV), which is then hydrogenated over Ni/Al and NaOH in EtOH to furnish amine (XV). Elimination of the tertiary alcohol (XV) by refluxing with HCl in EtOH gives substituted diphenylpropenamine hydrochloride (XVI), which is hydrogenated over Pd/C in EtOH and finally subjected to hydrochloride salt neutralization.

1 Moe, S.T.; Mueller, A.L.; Vanwagenen, B.C.; Barmore, R.M.; Delmar, E.G.; Artman, L.D.; Balandrin, M.F.; Smith, D.L. (NPS Pharmaceuticals, Inc.); Cpds. active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases. WO 9746511 .
2 Barmore, R.M.; DelMar, E.G.; Balandrin, M.F.; VanWagenen, B.C.; Artman, L.D.; Mueller, A.L.; Moe, S.T. (NPS Pharmaceuticals, Inc.); Cpds. active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases. US 6071970 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 10045 Diethyl cyanomethylphosphonate 2537-48-6 C6H12NO3P 详情 详情
(VIII) 35077 bis(3-fluorophenyl)methanone 345-70-0 C13H8F2O 详情 详情
(IX) 35078 3,3-bis(3-fluorophenyl)acrylonitrile C15H9F2N 详情 详情
(X) 35079 3,3-bis(3-fluorophenyl)propanenitrile C15H11F2N 详情 详情
(XI) 48851 3,3-bis(3-fluorophenyl)-1-propanamine; 3,3-bis(3-fluorophenyl)propylamine C15H15F2N 详情 详情
(XII) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(XIII) 48852 3,3-bis(3-fluorophenyl)propylformamide C16H15F2NO 详情 详情
(XIV) 37211 3,3-bis(3-fluorophenyl)-3-hydroxypropanenitrile C15H11F2NO 详情 详情
(XV) 37212 3-amino-1,1-bis(3-fluorophenyl)-1-propanol C15H15F2NO 详情 详情
(XVI) 37213 3,3-bis(3-fluorophenyl)-2-propen-1-amine; 3,3-bis(3-fluorophenyl)-2-propenylamine C15H13F2N 详情 详情

合成路线12

该中间体在本合成路线中的序号:(II)

Claisen reaction between ethyl caproate (I) and ethyl formate (II) in the presence of NaOEt affords formyl derivative (III), which is then condensed with O-benzyl hydroxylamine hydrochloride (IV) by means of NaOAc in EtOH/H2O to yield derivative (V). Hydrolysis of the ethyl ester moiety of (V) by treatment with aqueous NaOH in MeOH provides carboxylic acid (VI), which is coupled to tert-leucine N,N-dimethylamide (VII) by means of EDC and HOAt to furnish compound (VIII). Reduction of the oxime moiety of (VIII) with NaCNBH3 in HOAc affords a mixture of diastereoisomers from which (R)-(IX) is separated by flash chromatography. Finally, treatment of (R)-(IX) with N-formyl-benzotriazole (HCOBt) in THF provides formamide (X), whose benzyl group is then removed by hydrogenation over Pd/C in MeOH.

1 Spavold, Z.M.; Launchbury, S.; Clements, J.M.; Hunter, M.G.; Davies, S.J.; Pratt, L.M.; Beckett, R.P.; Whittaker, M. (British Biotech Pharmaceuticals Ltd.); Antibacterial agents. WO 9939704 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIIa) 45887 (2R)-2-[[(benzyloxy)imino]methyl]-N-[(1S)-1-[(dimethylamino)carbonyl]-2,2-dimethylpropyl]hexanamide C22H35N3O3 详情 详情
(VIIIb) 45890 (2S)-2-[[(benzyloxy)imino]methyl]-N-[(1S)-1-[(dimethylamino)carbonyl]-2,2-dimethylpropyl]hexanamide C22H35N3O3 详情 详情
(I) 51702 Ethyl caproate; Ethyl n-Caproate; Caproic acid ethyl ester; n-Caproic acid ethylester; Capronic Ether; Isoamyl acetate; Hexanoic acid ethyl ester; Ethyl hexanoate 123-66-0 C8H16O2 详情 详情
(II) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(III) 45886 (2S)-2-amino-N,N,3,3-tetramethylbutanamide C8H18N2O 详情 详情
(IV) 14640 O-benzylhydroxylamine; 1-[(aminooxy)methyl]benzene 622-33-3 C7H9NO 详情 详情
(V) 45884 ethyl 2-[[(benzyloxy)imino]methyl]hexanoate C16H23NO3 详情 详情
(VI) 45885 2-[[(benzyloxy)imino]methyl]hexanoic acid C14H19NO3 详情 详情
(VII) 45886 (2S)-2-amino-N,N,3,3-tetramethylbutanamide C8H18N2O 详情 详情
(IX) 45888 (2R)-2-[[(benzyloxy)amino]methyl]-N-[(1S)-1-[(dimethylamino)carbonyl]-2,2-dimethylpropyl]hexanamide C22H37N3O3 详情 详情
(X) 45889 (2R)-2-[[(benzyloxy)(formyl)amino]methyl]-N-[(1S)-1-[(dimethylamino)carbonyl]-2,2-dimethylpropyl]hexanamide C23H37N3O4 详情 详情

合成路线13

该中间体在本合成路线中的序号:(V)

The chiral intermediate (X) is prepared by two methods. Treatment of lactonitrile (I) with HCl/EtOH affords imidate (II), which is further reacted with ethanolic ammonia to produce amidine (III). Claisen condensation between ethyl acetate (IV) and ethyl formate (V) in the presence of NaH provides the sodium salt of ethyl 3-hydroxyacrylate (VI). Cyclization of (VI) with amidine (III) then furnishes the racemic pyrimidinone (VII). Kinetic resolution of (VII) is accomplished by acylation with vinyl butyrate (VIII) in the presence of lipase P30 to yield a mixture of unreacted (S)-alcohol (IX) and the desired (R)-butyrate ester (X), which can be separated by partition between CH2Cl2 and H2O.

1 Mylari, B.L.; Zembrowski, W.J.; Murry, J.A.; Chu-Moyer, M.Y. (Pfizer Products Inc.); Aminopyrimidines as sorbitol dehydrogenase inhibitors. EP 1185275; US 6414149; WO 0059510 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 64060 2-hydroxypropanenitrile C3H5NO 详情 详情
(II) 64061 ethyl 2-hydroxypropanimidoate C5H11NO2 详情 详情
(III) 64062 2-hydroxypropanimidamide C3H8N2O 详情 详情
(IV) 17491 ethyl acetate 141-78-6 C4H8O2 详情 详情
(V) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(VI) 64063 sodium (E)-3-ethoxy-3-oxo-1-propen-1-olate C5H7NaO3 详情 详情
(VII) 64064 2-(1-hydroxyethyl)-4(3H)-pyrimidinone C6H8N2O2 详情 详情
(VIII) 53263 n-Butyric acid vinyl ester; Vinyl n-butyrate; Vinyl butyrate 123-20-6 C6H10O2 详情 详情
(IX) 64065 2-[(1S)-1-hydroxyethyl]-4(3H)-pyrimidinone C6H8N2O2 详情 详情
(X) 64066 (1R)-1-(6-oxo-1,6-dihydro-2-pyrimidinyl)ethyl butyrate C10H14N2O3 详情 详情

合成路线14

该中间体在本合成路线中的序号:(I)

 

1 Khamar BM, Modi IA, Shukla MC, et aL. 2006. A process for the preparation of zaleplon. W0 2006070244
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(II) 66968 1-(3-bromophenyl)ethanone 2142-63-4 C8H7BrO 详情 详情
(III) 66969 sodium 1-(3-bromophenyl)-1,3-dioxopropan-2-ide   C9H6BrNaO2 详情 详情
(IV) 11987 3-Amino-4-pyrazolecarbonitrile; 3-Amino-1H-pyrazole-4-carbonitrile; 3-Amino-4-cyanopyrazole 16617-46-2 C4H4N4 详情 详情
(V) 66970 7-(3-bromophenyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile 933054-30-9 C13H7BrN4 详情 详情
(VI) 66971 N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)acetamide 115931-01-6 C15H11N5O 详情 详情

合成路线15

该中间体在本合成路线中的序号:(I)

 

1 Horns S. 2003. Method for producing N-ethyl-N-[3-(3-cyanopyrazolo [1, 5α] pyrimidin-7-yl) phenyl] acetamide (zaleplon). W0 2003068775
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(II) 66973 N-(3-acetylphenyl)-N-ethylacetamide   C12H15NO2 详情 详情
(III) 66974 sodium 1-(3-(N-ethylacetamido)phenyl)-1,3-dioxopropan-2-ide   C13H14NaNO3 详情 详情
(IV) 11987 3-Amino-4-pyrazolecarbonitrile; 3-Amino-1H-pyrazole-4-carbonitrile; 3-Amino-4-cyanopyrazole 16617-46-2 C4H4N4 详情 详情

合成路线16

该中间体在本合成路线中的序号:(XVIII)

Condensation of 4-hydroxy-3-methoxyacetophenone (XIII) with mesylate (XIV) by means of K2CO3 in DMF at 100 °C yields the aryl ether (XV), which by nitration using HNO3 in AcOH gives the corresponding o-nitroaryl ketone (XVI). Reduction of the nitro group in compound (XVI) using Fe and NH4Cl in refluxing EtOH/H2O gives amine (XVII). Friedlaender cyclization of the o-aminoaryl ketone (XVII) with ethyl formate (XVIII) and NaOMe in DME affords a 4-hydroxyquinoline derivative, which without isolation is chlorinated using POCl3 to produce the corresponding chloride (XIX). Condensation of the aryl chloride (XIX) with 6-hydroxy-N-methyl-1-naphthamide (V) in the presence of DMAP in refluxing dioxane gives adduct (XX), whose methyl ester is hydrolyzed with NaOH in refluxing MeOH to afford acid (XXI). Activation of acid (XXI) with i-BuOCOCl in the presence of DIEA in acetone and subsequent substitution of the obtained mixed anhydride with NaN3 produces azide (XXII), which is finally treated with PhCH2OH in refluxing toluene .

1 Chen, G.P. (Advenchen Laboratories, LLC). Spiro substituted compounds as angiogenesis inhibitors. KR 2015039889; US 8163923; EP 2125777; JP 2010521474; WO 2008112408; US 2008227812.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 67629 6-hydroxy-N-methyl-1-naphthamide   C12H11NO2 详情 详情
(XIII) 22604 1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone 498-02-2 C9H10O3 详情 详情
(XIV) 67637 1-(4-hydroxy-3-methoxyphenyl)ethanone   C7H12O5S 详情 详情
(XV) 67638 methyl 1-((4-acetyl-2-methoxyphenoxy)methyl)cyclopropanecarboxylate   C15H18O5 详情 详情
(XVI) 67639 methyl 1-((4-acetyl-2-methoxy-5-nitrophenoxy)methyl)cyclopropanecarboxylate   C15H17NO7 详情 详情
(XVII) 67640 methyl 1-((4-acetyl-5-amino-2-methoxyphenoxy)methyl)cyclopropanecarboxylate   C15H19NO5 详情 详情
(XVIII) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(XIX) 67641 methyl 1-(((4-chloro-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropanecarboxylate   C16H16ClNO4 详情 详情
(XX) 67642 methyl 1-(((6-methoxy-4-((5-(methylcarbamoyl)naphthalen-1-yl)oxy)quinolin-7-yl)oxy)methyl)cyclopropanecarboxylate C28H26N2O6 详情 详情
(XXI) 67643 1-(((6-methoxy-4-((5-(methylcarbamoyl)naphthalen-1-yl)oxy)quinolin-7-yl)oxy)methyl)cyclopropanecarboxylic acid   C27H24N2O6 详情 详情
(XXII) 67644 1-(((6-methoxy-4-((5-(methylcarbamoyl)naphthalen-1-yl)oxy)quinolin-7-yl)oxy)methyl)cyclopropanecarbonyl azide   C27H23N5O5 详情 详情

合成路线17

该中间体在本合成路线中的序号:(XXI)

Alkylation of 4’-hydroxy-3’-methoxyacetophenone (XVII) with benzyl bromide by means of K2CO3 in DMF gives benzyl ether (XVIII), which is reacted with fuming HNO3 and concentrated H2SO4 in cold CH2Cl2 to afford 4’-benzyloxy-5’-methoxy-2’-nitroacetophenone (XIX). After reduction of the nitro group of compound (XIX) using iron powder and ammonium formate in refluxing H2O/toluene, the resulting 2-aminoacetophenone derivative (XX) cyclizes with ethyl formate (XXI) in the presence of NaOEt in DME, providing 7-benzyloxy-6-methoxy-4-quinolinol (XXII). Finally, quinolinol (XXII) is treated with trifluoromethanesulfonyl chloride in the presence of DMAP and 2,6-lutidine in cold CH2Cl2 .

1 Deschamps, N.M., Martin, M.T., Monteith, M.J., Zhou, X. (GlaxoSmithKline Inc.). Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide. US 2010081805, WO 010036831.
2 Wilson, J., Zuberi, S., Naganathan, S., Goldman, E., Kanter, J. (Exelixis, Inc.). Methods of preparing quinoline derivatives. WO 2010056960.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXIVa) 22605 4-(3-Chloropropoxy)-3-Methoxyacetophenone;3-(4-Acetyl-2-methoxyphenoxy)propyl chloride;1-(4-(3-chloropropoxy)-3-methoxyphenyl)ethanone;1-[4-(3-chloropropoxy)-3-methoxyphenyl]-1-ethanone 58113-30-7 C12H15ClO3 详情 详情
(XXIVb) 69115 1-(4-(3-bromopropoxy)-3-methoxyphenyl)ethanone   C12H15BrO3 详情 详情
(XXVa) 69117 1-(4-(3-chloropropoxy)-5-methoxy-2-nitrophenyl)ethanone   C12H14ClNO5 详情 详情
(XXVb) 69116 1-(4-(3-bromopropoxy)-5-methoxy-2-nitrophenyl)ethanone C12H14BrNO5 详情 详情
(VI) 69105 4-chloro-6-methoxy-7-(3-morpholinopropoxy)quinoline;4-(3-((4-chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine   C17H21ClN2O3 详情 详情
(XVII) 22604 1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone 498-02-2 C9H10O3 详情 详情
(XXI) 16602 ethyl formate 109-94-4 C3H6O2 详情 详情
(XXIII) 10358 1-Bromo-3-chloropropane 109-70-6 C3H6BrCl 详情 详情
(XXVI) 10388 Morpholine 110-91-8 C4H9NO 详情 详情
(XXVII) 69118 1-(5-methoxy-4-(3-morpholinopropoxy)-2-nitrophenyl)ethanone   C16H22N2O6 详情 详情
(XXVIII) 56891 1,3-propanediol cyclic sulfate;1,3,2-dioxathiane 2,2-dioxide;1,3-Propylene sulfate 1073-05-8 C3H6O4S 详情 详情
(XXIX) 69119 4’-(morpholinopropoxy)acetophenone;1-(3-methoxy-4-(3-morpholinopropoxy)phenyl)ethanone   C16H23NO4 详情 详情
(XXX) 69120 1-(2-amino-5-methoxy-4-(3-morpholinopropoxy)phenyl)ethanone   C16H24N2O4 详情 详情
(XXXI) 69121 6-methoxy-7-(3-morpholinopropoxy)quinolin-4-ol   C17H22N2O4 详情 详情
(XXXII) 20360 methyl(phenyl)formamide;N-Methylformanilide;N-Formyl-N-methylaniline;Methylphenylformamide;N-methyl-N-phenylformamide;N-Methyl-N-formylaniline;N-Formyl-N-methylaniline 93-61-8 C8H9NO 详情 详情
Extended Information